Home / Insulin Glargine / United States
US ATC A10AE04 · updated 2 Nov 2026
Insulin Glargine shortage in United States
Is there an Insulin Glargine shortage in United States?
Yes. As of 2 Nov 2026, 1 Insulin Glargine product is reported short in United States, the first since 1 Sep 2026. No return date has been given. Main reason: not stated.
Also short in Canada, France, Italy, Austria, Japan. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Rezvoglar, Injection, 100 [iU]/1 mL (NDC 0002-8980-05) discontinuation | Eli Lilly and Co. | 1 Sep 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).